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OBJECTIVES The aim of this study was to investigate the effects of angiotensin II (Ang II) on fibroblast
proliferation and endothelin-1 (ET-1) gene induction, focusing especially on reactive oxygen
species (ROS)-mediated signaling in cardiac fibroblasts.
BACKGROUND Angiotensin II increases ET-1 expression, which plays an important role in Ang II-induced
fibroblast proliferation. Angiotensin II also stimulates ROS generation in cardiac fibroblasts.
However, whether ROS are involved in Ang II-induced proliferation and ET-1 expression
remains unknown.
METHODS Cultured neonatal rat cardiac fibroblasts were stimulated with Ang II, and then [3H]thymi-
dine incorporation and the ET-1 gene expression were examined. We also examined the
effects of antioxidants on Ang II-induced proliferation and mitogen-activated protein kinase
(MAPK) phosphorylation to elucidate the redox-sensitive pathway in fibroblast proliferation
and ET-1 gene expression.
RESULTS Both AT1 receptor antagonist (losartan) and ETA receptor antagonist (BQ485) inhibited
Ang II-increased DNA synthesis. Endothelin-1 gene was induced with Ang II as revealed by
Northern blotting and promoter activity assay. Angiotensin II increased intracellular ROS
levels, which were inhibited with losartan and antioxidants. Antioxidants further suppressed
Ang II-induced ET-1 gene expression, DNA synthesis, and MAPK phosphorylation.
PD98059, but not SB203580, fully inhibited Ang II-induced ET-1 expression. Truncation
and mutational analysis of the ET-1 gene promoter showed that AP-1 binding site was an
important cis-element in Ang II-induced ET-1 gene expression.
CONCLUSIONS Our data suggest that ROS are involved in Ang II-induced proliferation and ET-1 gene
expression. Our findings imply that the combination of ATI and ETA receptor antagonists
plus antioxidants may be beneficial in preventing the formation of excessive cardiac
fibrosis. (J Am Coll Cardiol 2003;42:1845–54) © 2003 by the American College of
Cardiology Foundation
Fibroblasts play an important role in maintaining cardiac
function by providing structural support for cardiomyocytes
and serving as a source for paracrine growth factors (1–3).
After myocardial infarction, reactive fibrosis results in excess
scar formation as proliferating fibroblasts invade the ne-
crotic area. This remodeling leads to the increase of the
ventricular stiffness and ultimately compromises the func-
tion of the heart. Angiotensin II (Ang II), the effector
peptide of the renin-angiotensin system, is now known to
have growth promoting properties in various cell types and
a mitogenic effect on cardiac fibroblasts (1,2,4). The growth
related cellular actions of Ang II are mediated by the AT1
receptor subtype (4). Recent reports have shown that Ang II
stimulates membrane-bound nicotinamide adenine dinucle-
otide phosphate (NADPH) oxidase, which generates reac-
tive oxygen species (ROS) in cardiac fibroblasts (3). In-
creased NADPH oxidase-derived ROS have recently been
reported to be potentially linked with a defect in cardiac
contractile function in a pathological setting (5); ROS may
act as second messengers that regulate various intracellular
signal transduction cascades and the activity of various
transcription factors. Activator protein-1 (AP-1) is one of
the best characterized transcription factors to be influenced
by the cellular oxidation reduction (redox) state (6,7). The
primary target of activation of AP-1 by ROS appears to be
the activation of mitogen-activated protein kinase (MAPK)
pathways, thereby leading to the phosphorylation and acti-
vation of the c-fos and c-jun family of protooncogenes. The
potential role of ROS in the regulation of signal transduc-
tion and gene expression in the heart has recently been
elucidated. Administration of antioxidants inhibited Ang
II-induced cardiac hypertrophy (8,9).
Fujisaki et al. (1) previously reported that Ang II-induced
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endothelin-1 (ET-1) gene expression in cardiac fibroblasts
may serve as an autocrine/paracrine growth factor for
cardiac fibroblasts. The promoter region of the ET-1 gene
contains at least two essential protein binding motifs cor-
responding to the transcription factors GATA and AP-1
(10). We reported that mechanical stretch-induced intra-
cellular ROS were involved in ET-1 gene induction par-
tially via the AP-1 activation in endothelial cells (11). Our
recent study further revealed that extracellular signal-
regulated kinase (ERK) pathway plays a crucial role in
ROS-mediated ET-1 gene expression in rat cardiac fibro-
blasts (12). Although the significance of ET-1 gene expres-
sion in cardiac fibroblasts has been recently determined, the
regulatory mechanism of ET-1 gene induction by Ang II
remains unclear. In the present study, we investigated the
role of redox-sensitive mechanisms in fibroblast prolifera-
tion and the ET-1 gene induction in cardiac fibroblasts
treated with Ang II. We further determined which redox-
sensitive signal transduction pathways and transcription
factors were involved in this process. This study shows that
ROS are essential for Ang II-induced proliferation and
ET-1 gene expression in cardiac fibroblasts. Our results
indicate that Ang II up-regulates the ET-1 gene at least in
part via Ras/Raf/ERK signaling pathways in cardiac fibro-
blasts.
METHODS
Materials. Dulbecco’s modified Eagle’s medium (DMEM)/
F-12, fetal calf serum, and tissue culture reagents were from
Invitrogen (Carlsbad, California). A rat ET-1 complemen-
tary DNA probe (accession No. M64711) was obtained as
previously described (13). A series of deletion mutants
containing various lengths of the ET-1 promoter region
fused to chloramphenicol acetyltransferase (CAT) reporter
gene and the catalytically inactive mutant of ERK2
(mERK2), RasN17, RasL61, and Raf301 were previously
described (11). The ECL detection system was from Am-
ersham Pharmacia Biotech (Buckinghamshire, UK).
PD98059 and SB203580 were from CALBIOCHEM
(Calbiochem-Novabiochem Corporation, La Jolla, Califor-
nia). Losartan, Ang II, PMA, NAC, and all other chemicals
were purchased from Sigma (St. Louis, Missouri).
Cell culture. Primary cultures of neonatal rat cardiac fibro-
blasts were prepared as previously described (12). Cells were
incubated with minimum essential medium (MEM) sup-
plemented with 10% fetal calf serum. Two to four days after
seeding, confluent non-myocytes were trypsinized and sub-
cultured. Subconfluent (70% confluency) cardiac fibro-
blasts grown in either 60- or 100-mm culture dishes from
the second to fourth passage were used for the experiments.
Serum-containing medium from these cultured cells was
replaced with serum-free medium and exposed to agents as
indicated.
DNA synthesis. To measure synthesis of new DNA, cells
(1  105/well) were plated in six-well (35-mm) dishes 24 h
before experiments. Cardiac fibroblasts were incubated with
[3H]thymidine (5 Ci/ml) at 4°C. After addition of agent
indicated, cells were then harvested with trichloroacetic acid
(5%) followed by solubilization in 0.1 N NaOH, and
radioactivity was determined by scintillation counting. Data
are presented as the mean SEM of 9 to 12 determinations
in three to four different cell preparations and normalized to
the untreated sample  100 (i.e., percentage of control).
Assay of intracellular ROS. Intracellular ROS production
was measured by using a fluorescent dye, 2 7-
dichlorofluorescin diacetate (DCF-DA) (Molecular Probes,
Eugene, Oregon) with the ACAS Interactive Laser Cytom-
eter (Meridian Instruments, Inc., Okemos, Michigan) as
previously described (12). Baseline values from unstimulated
cells were used as control values by comparing them with
Ang II-stimulated cells. Values represent means  SEM of
DCF fluorescence from 20 randomly selected cells in each
experiment for six separate investigations.
RNA isolation and Northern blot analysis. Total RNA
was isolated from cardiac fibroblasts by the guanidine
isothiocyanate/phenol chloroform method as previously de-
scribed (11). The RNA (10 g/lane) was separated by
electrophoresis on a 1% agarose formaldehyde gel and
transferred onto a nylon membrane (Nytran, Schleicher &
Schuell, Inc., Germany) by a vacuum blotting system
(VacuGene XL, Pharmacia, Buckinghamshire, UK). After
hybridization with the 32P-labeled ET-1 complementary
DNA probes, the membrane was washed with 0.1 sodium
chloride plus tris-sodium citrate containing 1% sodium
dodecyl sulfate at 42°C for 30 min and then exposed to
X-ray film at 70°C. Blots of specific messenger RNA
(mRNA) bands were detected by autoradiography and
analyzed with a densitometer (Computing Densitometer
300S, Molecular Dynamics, Sunnyvale, California). Blots
were stripped and reprobed for 18S complementary DNA
probe (obtained from American Type Culture Collection,
Abbreviations and Acronyms
Ang II  angiotensin II
AP-1  activator protein-1
AT1  angiotensin II type 1 receptor
CAT  chloramphenicol acetyltransferase
DCF-DA  dichlorofluorescin diacetate
DPI  diphenyleneiodonium
ECM  extracellular matrix
ERK  extracellular signal-regulated kinase
ETA  ET-1 type A receptor
ET-1  endothelin-1
GPCRs  G-protein coupled receptors
JNK  c-Jun N-terminal kinase
MAPK  mitogen-activated protein kinase
MEK  MAPK/ERK kinase
mRNA  messenger RNA
NAC  N-acetylcysteine
redox  cellular oxidation reduction
ROS  reactive oxygen species
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Manassas, Virginia) to control for loading. Expression of
ET-1 mRNA was quantitated and was normalized to the
18S signal.
Transfection and chloramphenicol acetyltransferase as-
says. For the transient transfections, cardiac fibroblasts
were transfected with different expression vectors by the
calcium phosphate method (12). DNA concentration for all
samples was adjusted to be equal with empty vector pSR in
each experiment. To correct for variability in transfection
efficiency, 5 g of pSV--galactosidase plasmid DNA was
co-transfected in all the experiments. The CAT and -
galactosidase assays were performed as previously described
(14). The relative CAT activity was corrected by normaliz-
ing the respective CAT value to that of -galactosidase
activity. Co-transfected -galactosidase activity varied by
10% within a given experiment and was not affected by
any of the experimental manipulations described. As posi-
tive and negative controls, pBLCAT2 (with thymidine
kinase promoter) and pBLCAT3 (without promoter) were
included in each assay.
Western blot analysis. Rabbit polyclonal anti-phospho-
specific p38MAPK, anti-phospho-specific ERK1/2, and
anti-phospho-specific c-Jun N-terminal kinase (JNK) anti-
bodies were purchased from New England Biolabs (Beverly,
Massachusetts). Anti-ERK1/2, anti-p38MAPK, and anti-
JNK antibodies were purchased from Santa Cruz Biotech-
nology, Santa Cruz, California. Western blot analysis was
performed as previously described (11).
Statistical analysis. Results are expressed as mean  SEM
of at least three experiments unless designated otherwise.
Statistical analysis was performed using analysis of variance
(ANOVA) and Student t test as appropriate. A value of p
0.05 was considered to be statistically significant.
RESULTS
Ang II-induced proliferation of cardiac fibroblast is
mediated via ET-1A receptor. Angiotensin II-stimulated
cardiac fibroblast proliferation was assessed by analyzing
DNA synthesis with [3H]thymidine incorporation. Angio-
tensin II increased DNA synthesis in neonatal rat cardiac
fibroblasts in a dose-dependent manner (Fig. 1A). The
maximum level of incorporation was 2.1-fold increase com-
pared with the control. Angiotensin II (100 nM)–
stimulated DNA synthesis in cardiac fibroblasts was inhib-
ited by either AT1 receptor antagonist losartan (1 M) or
ETA receptor antagonist BQ485 (1 M) treatment (Fig.
1B). Both losartan and BQ485 had no effect on basal
[3H]thymidine uptake. These data suggest the possible role
of endogenous ET-1 as an autocrine growth factor for the
proliferation of cardiac fibroblasts under Ang II stimulation.
Ang II-induced ET-1 gene expression in cardiac fibro-
blasts. To confirm that Ang II increases ET-1 mRNA
levels in cardiac fibroblasts, we performed Northern blot
analysis (Figs. 2A and 2B). Endothelin-1 mRNA was
induced by Ang II (100 nM) as early as 30 min and then
returned to the basal level after 2 h (Fig. 2A). When cardiac
fibroblasts were treated with Ang II for 30 min, the Ang
II-induced ET-1 mRNA expression was dose-dependent
with the maximum induction at 100 nM (Fig. 2B). To
determine whether the Ang II-induced ET-1 expression is
regulated at the transcriptional level, an ET-1 promoter
construct containing the ET-1 promoter region (4.4 kb)
and the reporter gene CAT was constructed and transiently
transfected into cardiac fibroblasts. Cardiac fibroblasts ex-
posed to 24 h of Ang II (100 nM) significantly increased
ET-1 promoter activity by 2.6-fold compared with un-
treated cells (Fig. 2C). The effect of AT1 receptor blocker
losartan on the Ang II-increased ET-1 promoter activity
was also investigated (Fig. 2C). Cardiac fibroblasts were
pretreated with losartan (1 M) for 1 h and subsequently
Figure 1. Characteristics of the activation of DNA synthesis by angioten-
sin II (Ang II) in cardiac fibroblasts. All experiments were performed with
the incorporation of [3H]thymidine into DNA. (A) Effect of Ang II
concentration on the DNA synthesis. Cells were incubated with the
indicated doses of Ang II for 24 h and then assayed for [3H]thymidine
incorporation. (B) Effect of Ang II or endothelin-1 receptor antagonists on
[3H]thymidine incorporation. Cells were preincubated with either losartan
(Losa) (1 M) or BQ485 (1 M) for 1 h followed by an incubation with 100
nM Ang II for 24 h. Experimental details are given in the Experimental
Procedures section. [3H]thymidine incorporation is expressed as the
percentage of increase relative to the [3H] content (100%) in the control
(C). All data are shown as the means  SEM of 9 to 12 determinations in
three to four different cell preparations. *p  0.05 versus control (Student
t test); #p  0.05 versus Ang II alone (analysis of variance).
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stimulated with Ang II for 24 h. The Ang II-induced ET-1
gene expression was inhibited by losartan. Angiotensin II
dose dependently increased ET-1 promoter activity; 100
nM of Ang II also gave maximum induction (Fig. 2D).
These data show that Ang II directly induces ET-1 gene
expression in cardiac fibroblasts.
Ang II-induced fibroblast proliferation and ET-1 gene
expression are redox-sensitive. We and others have dem-
onstrated that Ang II stimulates ROS production in various
cell types, including cardiomyocytes and cardiac fibroblasts
(3,8,9). To confirm that Ang II induces intracellular ROS in
cardiac fibroblasts, we measured intracellular ROS level by
analyzing the fluorescent product DCF, a peroxidative
product of DCFDA, with laser-scanning confocal micros-
copy. Cardiac fibroblasts treated with Ang II (100 nM) had
significantly higher ROS levels than those cells treated with
vehicle only (Fig. 3A). The increase of ROS was completely
blocked by pretreatment of cells with either losartan or
antioxidants such as catalase or N-acetylcysteine (NAC).
Interestingly, cells treated with a flavoprotein containing the
NADH/NADPH oxidase inhibitor, diphenyleneiodonium
(DPI) also showed a significant reduction in ROS produc-
Figure 2. Effect of angiotensin II (Ang II) on endothelin-1 (ET-1) gene expression in neonatal rat cardiac fibroblasts. (A) Time course of Ang II on ET-1
messenger RNA (mRNA) expression. Cells were incubated with Ang II (100 nM) for the indicated times. (B) Dose-dependent effect of Ang II on ET-1
mRNA expression. Cells were incubated with various doses of Ang II for 30 min. (C) Time course of Ang II-increased ET-1 promoter activity. Cardiac
fibroblasts were transfected with chimeric ET-1 promoter-chloramphenicol acetyltransferase (CAT) fusion genes followed by treatment with Ang II (100
nM) for the time indicated or pretreated with losartan (Losa) (1 M) for 1 h followed by Ang II stimulation. (D) Induction of ET-1 promoter activity by
different concentration of Ang II. Cells were harvested, and CAT activities were measured as described in the Experimental Procedures section. Control
(C), no drugs; CAT2 and CAT3 are shown as positive and negative control; CAT activities are shown as the percentage of incorporation after normalizing
to that of -galactosidase activities. Data are represented as difference relative to control groups. The results are shown as mean  SEM (n  3 per group).
*p  0.05 vs. control (Student t test); #p  0.05 vs. Ang II alone (analysis of variance). The experiment was repeated three times with reproducible
results.
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tion (Fig. 3A). To elucidate the involvement of ROS in the
Ang II-induced fibroblast proliferation, cardiac fibroblasts
were pretreated with NAC or catalase for 30 min followed
by Ang II treatment. Cardiac fibroblasts pretreated with
NAC (10 mM) or catalase (350 U/ml) significantly sup-
pressed Ang II-induced [3H]thymidine uptake (Fig. 3B).
To further examine the ROS involvement in the Ang
II-induced ET-1 gene expression, cardiac fibroblasts were
preincubated with an antioxidant NAC or catalase for 30
min and then treated with Ang II. As shown in Figure 3C,
cardiac fibroblasts pretreated with NAC (10 mM) or cata-
lase (350 U/ml) significantly suppressed Ang II-induced
ET-1 mRNA level. Similarly, cells pretreated with NAC or
catalase also suppressed Ang II-increased ET-1 promoter
activity (Fig. 3D). These findings suggest that intracellular
ROS generation plays an important role in Ang II-induced
proliferation of cardiac fibroblasts and apparently mediate
Ang II-induced ET-1 gene expression.
Ang II-induced ET-1 gene expression is mediated via
Ras/Raf/ERK signaling pathway. Angiotensin II has
been shown to activate ERK, JNK, and p38MAPK in
cardiac fibroblasts, and the activation of these pathways is
redox-sensitive (3). To study whether these pathways were
involved in Ang II-induced ET-1 gene expression in cardiac
fibroblasts, we examined the effect of antioxidants on each
MAPK pathway and determined the effect of MAPK
inhibitors on Ang II-induced ET-1 gene expression. We
first confirmed that Ang II increases phosphorylation of
ERK1/2, p38MAPK, and JNK in cardiac fibroblasts (Figs.
4A to 4C). Both catalase (350 U/ml) and NAC (10 mM)
significantly inhibited Ang II-induced phosphorylation of
ERK1/2, p38MAPK, and JNK (Figs. 4A to 4C). These
Figure 3. Angiotensin II (Ang II)-induced proliferation and endothelin-1 (ET-1) gene expression were mediated by reactive oxygen species (ROS) in
cardiac fibroblasts. (A) Angiotensin II increased intracellular ROS in cardiac fibroblasts. Cardiac fibroblasts were loaded with dichlorofluorescin diacetate
for 30 min and stimulated with Ang II for 30 min. Intracellular ROS levels were measured by laser-confocal microscopy. Angiotensin II (100 nM) increased
ROS levels in cardiac fibroblasts, and these increases were abolished by losartan (Losa; 1 M), the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI)
(1 M), catalase (350 U/ml), or N-acetylcysteine (NAC) (10 mM). Cells treated with H2O2 are used as positive control. In each experiment, the
densitometric analysis was performed on at least 20 cells. (B) Effect of antioxidants on Ang II-induced DNA synthesis in cardiac fibroblasts. Cells were
preincubated with NAD(P)H oxidase inhibitor DPI (1 M), catalase (350 U/ml), or NAC (10 mM) for 30 min followed by incubation with 100 nM Ang
II for 24 h. Increases in [3H]thymidine incorporation are each expressed relative to the [3H] content (100%) in the respective control (C). (C) Effect of
antioxidants on Ang II-induced ET-1 messenger RNA in cardiac fibroblasts. Cells were preincubated with either the catalase (350 U/ml) or NAC (10 mM)
for 30 min followed by an incubation with 100 nM Ang II for 30 min. (D) Effect of antioxidants on Ang II-increased ET-1 promoter activity in cardiac
fibroblasts. Cells were preincubated with either the catalase (350 U/ml) or NAC (10 mM) for 30 min followed by an incubation with 100 nM Ang II for
24 h. The results are shown as mean  SEM (n  3 per group). *p  0.05 vs. control (Student t test); #p  0.05 vs. Ang II alone (analysis of
variance).
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Figure 4. Angiotensin II (Ang II) increased ET-1 gene expression via extracellular signal-regulated kinase (ERK) in a redox-sensitive manner. (A to C)
Angiotensin II-induced activation of ERK, c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38MAPK) was mediated by
reactive oxygen species-sensitive pathway. Cells were preincubated with either the catalase (350 U/ml) or N-acetylcysteine (NAC) (10 mM) for 30 min and
stimulated with Ang II (100 nM) for 30 min. Phosphorylation of ERK, JNK, or p38MAPK was detected by Western blotting using anti-phospho-ERK,
phospho-JNK, and phospho-p38MAPK antibodies. Both catalase and NAC inhibited Ang II-induced activation of ERK, JNK, or p38MAPK.
Phosphorylations of ERK, JNK, or p38MAPK were detected, and densitometric analyses were performed. The results are shown as mean  SEM (n 
4 per group). (D) Angiotensin II-induced ET-1 messenger RNA was attenuated by PD98059 in cardiac fibroblasts. Cardiac fibroblasts were stimulated
with Ang II (100 nM) in the presence of PD98059 (PD; 20 M) or SB203580 (SB; 20 M), and total RNA was isolated at 30 min. (E) Angiotensin
II-increased ET-1 promoter activity was inhibited by PD98059 in cardiac fibroblasts. Cardiac fibroblasts were stimulated with Ang II (100 nM) in the
presence of PD98059 (PD; 20 M) or SB203580 (SB; 20 M), and chloramphenicol acetyltransferase (CAT) activity was assayed after 24 h. (F) Angiotensin
II-increased ET-1 promoter activity via Ras/Raf/ERK pathway in cardiac fibroblasts. Cells, transfected with either pSR-empty vector (5 g), or an
expression plasmid encoding the dominant negative mutant mERK, Raf301, or RasN17 (5 g), were co-transfected with 15 g of ET-1 promoter-CAT
plasmid. Cells co-transfected with ET-1 promoter-CAT plasmid and an expression plasmid encoding MEK1 (5 g) or RasL61 (5 g) were used as positive
controls. The results are shown as mean  SEM (n  3 per group). *p  0.05 vs. control (Student t test); #p  0.05 versus Ang II alone (analysis of
variance).
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data suggest that ERK1/2, p38MAPK, and JNK are crucial
components of the redox-sensitive signaling pathways acti-
vated by Ang II in cardiac fibroblasts. We next determined
the role of redox-sensitive activation of MAPKs in Ang
II-induced ET-1 gene expression. PD98059, a specific
inhibitor of MKK-1 (ERK kinase [MEK]), inhibited aug-
mentation of ET-1 mRNA expression stimulated with Ang
II (Fig. 4D). SB203580, a specific inhibitor of p38 MAPK,
failed to fully inhibit this expression (Fig. 4D). Similarly,
co-incubation with PD98059 also completely abolished
Ang II-increased ET-1 promoter activity, but co-
incubation with SB203580 had no significant effect (Fig.
4E). These findings suggest that activation of ERK is a
necessary step for ET-1 gene expression induced with Ang II.
To identify the signaling pathway involved in the Ang
II-induced ET-1 expression, we also co-transfected cardiac
fibroblasts with various dominant negative mutants Ras
(RasN17), Raf-1 (Raf301), or a catalytically inactive mutant
of ERK2 (mERK), all of which are associated with the
Ras/Raf/ERK pathway. Cardiac fibroblasts co-transfected
with the empty vector PSR, as control revealed no effect on
Ang II-induced ET-1 promoter activity (Fig. 4F). How-
ever, cells co-transfected with RasN17, Raf301, or mERK
resulted in a significant inhibition in Ang II-induced ET-1
promoter activity. In contrast, cardiac fibroblasts co-
transfected with a dominant positive mutant of Ras
(RasL61) or MEK1 greatly increased their ET-1 promoter
activities. These results further suggest that the Ras/Raf/
ERK signaling pathway plays an important role in Ang
II-induced ET-1 gene expression in cardiac fibroblasts.
Identification of Ang II-responsive regulatory elements
in the ET-1 promoter. The ET-1 promoter contains a
number of AP-1 and GATA sites that can be regulated by
multiple activation pathways (10,15). We dissected the Ang
II-responsive elements of the ET-1 promoter in cardiac
fibroblasts. As previously described (11), a series of deletion
mutants containing various lengths of the ET-1 promoter
region fused to CAT reporter gene were transfected into
cardiac fibroblasts, and CAT activity was measured in
response to Ang II stimulation. Angiotensin II stimulation
for 24 h significantly increased CAT activity by 2.5- and
2.2-fold in700CAT and204CAT, respectively, both of
which contain multiple transcription factor binding sites,
including GATA (base pair [bp] 136 to 131) and AP-1
(bp 108 to 102) sites. However, after further truncation
of the GATA and subsequent AP-1 site from the 5-end,
the increase of the Ang II-induced ET-1 promoter activity
was completely abolished in both 129CAT and
98CAT. It is interesting that deletion of these two sites
also resulted in a significant decrease in basal promoter
activity (Fig. 5A). These findings suggest that the GATA
site as well as the AP-1 site are necessary for Ang II-
stimulated ET-1 gene induction. We further examined
whether AP-1 site is essential for the induction of ET-1
gene by Ang II. In cells transfected with reporter construct
204CAT containing both GATA and AP-1 sites with
two-bp mutation in the AP-1 site, the Ang II-induced
ET-1 promoter activity was completely abolished. In addi-
tion, the basal promoter activity also decreased compared
with control (Fig. 5B). These findings suggest that the
AP-1 binding element is essential for the induction of ET-1
gene by Ang II. Moreover, pretreating cells with antioxi-
dants, NAC, or catalase attenuated the Ang II-stimulated
AP-1 binding activity (data not shown). These results
clearly indicate that ROS mediate the transcriptional activ-
Figure 5. Identification of angiotensin II (Ang II)-responsive cis-elements
in endothelin 1 (ET-1) promoter. (A) A series of deletion mutants
containing various lengths of ET-1 promoter region were transfected into
cardiac fibroblasts. Transfected cells were stimulated with Ang II (100 nM)
for 24 h, and chloramphenicol acetyltransferase (CAT) activities were
measured. Stepwise 5-deletion constructs were depicted (top). Bars
represent mean (SEM, n  3 per group). CAT activity of each construct
in the presence or absence of Ang II were assayed. CAT 2 and CAT 3 were
used as positive or negative controls for CAT assay respectively (bottom).
(B) Wild type (204 bp) or AP-1 mutant of ET-1 promoter-CAT plasmid
was transfected into cardiac fibroblasts. Cells were stimulated with Ang II
(100 nM) for 24 h. The mutation of AP-1 strongly abolished the
responsiveness to Ang II stimulation. The results are shown as mean 
SEM (n  3 per group). *p  0.05 versus control (Student t test); #p 
0.05 versus Ang II alone (analysis of variance).
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ity of AP-1 induced by Ang II, and the AP-1 binding
element is responsible for the induction of ET-1 gene
expression by Ang II in cardiac fibroblasts.
DISCUSSION
The heart is composed of not only cardiac myocytes but also
nonmyocytes, particularly fibroblasts (16). Unlike cardiac
myocytes, cardiac fibroblasts can proliferate and increase the
deposition of extracellular matrix (ECM) proteins such as
fibronectin and collagen, which leads to interstitial fibrosis
(17). Therefore, fibroblasts play a crucial role in the devel-
opment of cardiac fibrosis, which enhances intrinsic myo-
cardial stiffness and results in diastolic dysfunction, account-
ing for 30% to 50% of congestive heart failure in clinical
practice (18,19). Recently, pharmacologic intervention with
angiotensin-converting enzyme inhibitors and AT1 receptor
antagonists has demonstrated that Ang II plays an impor-
tant role in the mediation of human hypertensive cardiac
fibrosis or pressure overload-induced cardiac fibrosis in rats
(20–25). Angiotensin II, the central product of the renin-
angiotensin system, has been shown to induce hypertrophy
of cardiomyocytes and hyperplasia of cardiac fibroblasts via
AT1 receptor. Recent in vitro study revealed that Ang
II-stimulated cardiomyocyte hypertrophy may be mediated
by paracrine release of ET-1 and transforming growth
factor-1 from fibroblasts rather than by direct action (2).
Animal study also revealed that the antioxidant dimethyl-
thiourea and probucol markedly improve left ventricular
remodeling in chronic heart failure, predominantly by re-
ducing cardiac fibrosis (26,27). In the present study, we
demonstrated that ROS mediate Ang II-induced fibroblast
proliferation and ET-1 gene expression in cardiac fibro-
blasts, and antioxidants significantly inhibit these effects,
consistent with findings of the above-mentioned in vivo
study. We further showed that ET-1 plays an important
role in Ang II-induced cardiac fibroblast proliferation in
autocrine fashion, in addition to its hypertrophic effect on
cardiomyocytes by paracrine action. These Ang II induc-
tions of both cardiomyocyte hypertrophy and fibroblast
proliferation, with concomitant production of ECM pro-
teins, lead to ventricular remodeling, dilation, and heart
failure. Our findings provide substantial evidence for new
therapeutic options with AT1 and ETA receptor antagonists
combined with antioxidants in congestive heart failure.
Angiotensin II has been shown to stimulate proliferation
of cardiac fibroblasts in culture (4). We characterized the
proliferative response to Ang II using agents that implicated
the AT1 receptor (losartan) and the ETA receptor (BQ485).
The Ang II-induced DNA synthesis in cardiac fibroblasts
was inhibited by both losartan and BQ485. These data are
compatible with Fujisaki et al. (1) in which an ETA receptor
antagonist blocked DNA synthesis induced by Ang II. It is
suggested that Ang II-induced proliferation of cardiac
fibroblasts is mediated by endogenous ET-1 produced by
cardiac fibroblasts in an autocrine/paracrine manner. Reac-
tive oxygen species have been implicated in inflammatory
processes such as fibrosis (28). It is also known that
antioxidants are capable of antagonizing the actions of Ang
II in many cell types (29). We previously reported that ROS
could modulate Ang II-induced -myosin heavy chain gene
expression in cardiomyocytes (9). To better understand the
role that ROS might play in influencing Ang II action in
cardiac fibroblasts, we have characterized the induction of
ET-1 gene and the activation of MAPKs in these cells by
Ang II and examined the effects of antioxidants NAC and
catalase on this pathway. In this study, we demonstrated
that ET-1 mediates Ang II-induced fibroblast proliferation
and ROS are involved in Ang II-induced activation of
MAPK pathways, which leads to ET-1 gene expression.
We also found that AP-1 site in the promoter region is a
crucial cis-element for Ang II-mediated induction of ET-1
gene in cardiac fibroblasts.
The MAPKs are a family of serine-threonine kinases,
which include ERK, JNK, and p38MAPK. Sano et al. (3)
reported that Ang II activates ERK1/2, p38MAPK, and
JNK partly through ROS in cardiac fibroblasts. Their
observation was in agreement with our present findings that
antioxidants significantly inhibit Ang II-induced activation
of the three classes of MAPKs. There are multiple pathways
leading to ERK activation by Ang II, which also differ
between cell types. These distinctive pathways might result
in different sensitivity for ROS. Several recent studies have
suggested that the balance of the oxidative and reductive
potentials (cellular redox state) within the cell may substan-
tially influence this pathway. Wang et al. (30) previously
reported that MEK1 was activated by Ang II and inhibited
by NAC, suggesting that it could be a potential site of
action for these drugs, although any site upstream of MEK1
also could be implicated. Our present findings suggest that
MEK1 is not the sole site of action, because both JNK and
p38MAPK activation were also inhibited by NAC and
catalase and these pathways are generally believed to be
independent of MEK1. We characterized the Ang II-
induced ET-1 gene expression using PD98059 that impli-
cated the requirement for MEK1 activation. However, we
could not completely rule out the role of p38MAPK in Ang
II-induced ET-1 gene expression, because SB203580 also
slightly reduced ET-1 mRNA expression stimulated by Ang
II. There is limited information regarding how activation of
G-protein coupled receptors (GPCRs) by Ang II leads to
activation of MEK/ERK pathway in cardiac fibroblasts.
However, the molecular mechanisms by which ROS regu-
late upstream signaling that lead to Ang II-induced ERK
phosphorylation and activation via liganded GPCRs in
cardiac fibroblasts remain to be further determined.
Accumulating evidence has made it clear that GPCRs
and receptor tyrosine kinases share a common pathway
converging in Ras (31). The non-receptor and receptor
tyrosine kinases have been implicated in Shc phosphoryla-
tion and Grb2/Sos recruitment thereby, connecting the
GPCR signal to Ras and ERK activation. Co-transfection
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experiments with dominant negative Ras, Raf, and ERK
suggested that the Ras-Raf-ERK pathway is involved in the
transcriptional activation of the ET-1 by Ang II because
they all inhibited the ET-1 promoter activity induced by
Ang II (Fig. 4F), whereas the empty vectors had no effect.
The ET-1 promoter contains an AP-1 element that could
be activated by ROS (10). Several evidences suggest that
ROS serve as messengers in AP-1 activation (7). The
cis-acting AP-1 element binds the protooncogene products
jun and fos (32), and it is well known that the genes for jun
and fos are activated by ROS (33). Using the gel mobility
shift assay, we found that Ang II increased binding of jun
and fos to the AP-1 site of the ET-1 gene promoter in a
redox-sensitive manner (data not shown). Truncation and
mutational analysis of the ET-1 gene promoter showed that
the AP-1 binding sequence is an important cis-element for
Ang II-induced ET-1 gene expression and that the GATA
site is also necessary for ET-1 gene induction by Ang II.
These results are consistent with the previous report by
Kawana et al. (15), showing that both the GATA and AP-1
sites are essential for ET-1 promoter function and that
cooperative interaction of GATA and AP-1 regulates the
transcription of the ET-1 gene in endothelial cells.
Conclusions. Angiotensin II via AT1 receptor increased
intracellular ROS, which were at least partly involved in
Ang II-induced proliferation and the Ang II-increased
activation of ERK, JNK, and p38MAPK pathways in
cardiac fibroblasts. Moreover, we showed that ERK activa-
tion plays a crucial role in Ang II-stimulated ET-1 gene
expression and mitogenic signaling. The ROS-MAPK
(ERK)–meditated AP-1-dependent transcription plays a
crucial role in Ang II-induced proliferation and ET-1 gene
expression in cardiac fibroblasts. The mechanism by which
ROS activated various signaling pathways remains undeter-
mined and should be clarified in the near future.
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